Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis

Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis

Bibliographic Details
Main Authors:	Spadaro, Melania, Gerdes, Lisa Ann, Krumbholz, Markus, Ertl-Wagner, Birgit, Thaler, Franziska Sabrina, Schuh, Elisabeth, Metz, Imke, Blaschek, Astrid, Dick, Andrea, Brück, Wolfgang, Hohlfeld, Reinhard, Meinl, Edgar, Kümpfel, Tania
Format:	Online
Language:	English
Published:	Lippincott Williams & Wilkins 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949775/

Similar Items

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
by: Spadaro, Melania, et al.
Published: (2015)

Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations
by: Schuh, Elisabeth, et al.
Published: (2015)

Neurological manifestations in autoinflammatory syndromes: a series of 131 patients from our neuroimmunology departement
by: Schuh, E, et al.
Published: (2015)

Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD
by: Yan, Yaping, et al.
Published: (2016)

P02-030 - Unusual CNS manifestation
by: Schuh, E, et al.
Published: (2013)

Multiple sclerosis–like lesions and type I interferon signature in a patient with RVCL
by: Schuh, Elisabeth, et al.
Published: (2014)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
by: S. Jarius, et al.
Published: (2018-05-01)

PW02-032 - CNS manifestations and NLRP3/CIAS1 gene mutations
by: Kümpfel, T, et al.
Published: (2013)

MOG antibody-associated diseases
by: Reindl, Markus, et al.
Published: (2015)

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
by: Pröbstel, Anne-Katrin, et al.
Published: (2015)

Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
by: Wuhrer, Manfred, et al.
Published: (2015)

CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis
by: Gerdes, Lisa Ann, et al.
Published: (2016)

Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis
by: Metz, Imke, et al.
Published: (2016)

Particle dynamics near Kerr-MOG black hole
by: M. Sharif, et al.
Published: (2017-05-01)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
by: Kim, Sung-Min, et al.
Published: (2015)

MOG-induced experimental autoimmune encephalomyelitis in the rat species triggers anti-neurofascin antibody response that is genetically regulated
by: Flytzani, Sevasti, et al.
Published: (2015)

Fingolimod induces neuroprotective factors in human astrocytes
by: Hoffmann, Franziska S., et al.
Published: (2015)

Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
by: Metz, Imke, et al.
Published: (2016)

Neurofascin as a novel target for autoantibody-mediated axonal injury
by: Mathey, Emily K., et al.
Published: (2007)

Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain
by: Saadoun, Samira, et al.
Published: (2014)

Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination
by: Carsten Tue Berg, et al.
Published: (2017-06-01)

High resolution multislice imaging of the fetal heart using iGRASP and MOG
by: Roy, Christopher, et al.
Published: (2016)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
by: Akaishi, Tetsuya, et al.
Published: (2016)

Cardiac sodium channel regulator MOG1 regulates cardiac morphogenesis and rhythm
by: Zhou, Juan, et al.
Published: (2016)

Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis
by: Chalmoukou, Konstantina, et al.
Published: (2015)

Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
Published: (2015)

Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
by: Chiuso-Minicucci, Fernanda, et al.
Published: (2015)

Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton
by: Dale, Russell C., et al.
Published: (2014)

MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS
by: Varrin-Doyer, Michel, et al.
Published: (2014)

Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE
by: Shetty, Aparna, et al.
Published: (2014)

Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration
by: Colombo, Emanuela, et al.
Published: (2012)

Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy
by: Metz, Imke, et al.
Published: (2011)

Interleukin-13 (IL-13)in autoimmune rheumatic diseases: relationship with autoantibody profile
by: Rinaldi, T, et al.
Published: (2001)

Distinct patterns of heavy chain variable region subgroup use by human monoclonal autoantibodies of different specificity
Published: (1988)

Blocking and Binding Folate Receptor Alpha Autoantibodies Identify Novel Autism Spectrum Disorder Subgroups
by: Frye, Richard E., et al.
Published: (2016)

Necrotizing infundibulo-hypophysitis: an entity too rare to be true?
by: Gutenberg, Angelika, et al.
Published: (2011)

Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons
by: Singh, Shailender, et al.
Published: (2013)

Limited TCF7L2 Expression in MS Lesions
by: Lürbke, Alexander, et al.
Published: (2013)

Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients
by: Patrice H. Lalive, et al.
Published: (2017-07-01)

Normalizers of intermediate congruence subgroups of the Hecke subgroups
by: Im Bo-Hae, et al.
Published: (2017-06-01)